Degeneration in the spinal cord in the cervical and thoracic region in Afghan Hounds (Afghan myelopathy, myelodystrophy, leukodystrophy)
- Occurrence: very rare
- Location of disease: Head/Neck
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetic disease that leads to degeneration of the central nervous system in dogs. This disease particularly affects the white matter in the brain and spinal cord and is primarily known in Afghan Hounds.
Das Wichtigste auf einen Blick
Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetic disease that primarily affects Afghan Hounds and causes degeneration of the central nervous system (CNS), particularly the myelin sheath of nerve fibers. This disease leads to disruption of neuronal communication and is inherited in an autosomal recessive manner, meaning affected dogs need two copies of the mutated gene to develop symptoms. Common symptoms include Hind limb movement disorder, uncoordinated gait, and tremors. Rarely, complete Paralysis of the legs and urinary incontinence can occur. Diagnosis is made through clinical examinations, imaging procedures such as MRI, and genetic tests to identify specific mutations.
A cure does not currently exist; treatment focuses on alleviating symptoms and improving quality of life through physiotherapy, medications, and nutritional support. The prognosis is unfavorable, as the disease is progressive and usually leads to significant neurological impairments. Preventive measures include responsible breeding practices and genetic tests to identify carriers of the mutation and avoid breeding them together. Research is focused on identifying genetic markers and developing potential therapies, including gene therapy approaches, to slow or stop the disease. Environmental factors are also being investigated to develop preventive measures to improve the well-being of affected dogs.
Ursachen
Myelodystrophy in dogs is a type of leukodystrophy characterized by progressive degeneration of the myelin sheaths. Myelin is a fatty substance that envelops and insulates nerve fibers, enabling efficient transmission of nerve impulses. In diseases like myelodystrophy, the integrity of the myelin layer is disrupted, impairing neuronal communication.
The disease is genetic and frequently occurs in certain breeds, particularly Afghan Hounds. Scientific studies suggest that it is an autosomal recessive hereditary disease, meaning a dog must inherit two copies of the mutated gene from both parents to develop the disease.
The exact genetic mutations that lead to myelodystrophy have been identified in some cases. Researchers are working to better understand the specific gene alterations to improve diagnoses and potential treatments. The identification of genetic markers could help in the future to detect affected dogs early and thus adjust breeding strategies.
Symptoms
The symptoms of myelodystrophy in dogs often begin at a young age, usually between the fourth and sixth month of life. The first signs include Coordination disorders, also called ataxia, which can manifest as an unsteady gait, Stumbling, or a loss of fine motor skills.
As the disease progresses, dogs may also develop signs of Paralysis. This Paralysis often initially affects the hind legs but can also affect the front legs and other parts of the body in advanced stages. Muscle strength decreases, and muscle atrophy can occur.
Additional symptoms may include behavioral changes such as apathy or Irritability as well as sensory impairments. In severe cases, Convulsions may also occur. The course of the disease is often variable but unfortunately predominantly progressive and worsens over time.
Diagnose
The diagnosis of myelodystrophy is based on a combination of clinical symptoms, breed predisposition, and specific diagnostic tests. A veterinarian will first conduct a thorough physical examination and obtain the dog’s medical history.
Advanced imaging techniques such as magnetic resonance imaging (MRI) can be used to visualize changes in the white matter of the brain and spinal cord. These changes are characteristic of leukodystrophies and support the diagnosis.
A genetic examination can also be performed to identify the specific mutations responsible for the disease. These tests are particularly useful for distinguishing the disease from other neurological disorders that can cause similar symptoms.
Therapie
Currently, there is no cure for myelodystrophy in dogs, and treatment aims to relieve symptoms and improve the quality of life of the affected animal. Physiotherapy can help maintain muscle strength and coordination for as long as possible.
In some cases, medications may be prescribed to control certain symptoms such as Pain or Convulsions. These therapies can improve quality of life, even though they cannot halt the progressive nature of the disease.
Nutritional support and supplements that promote nerve health may also be beneficial. Close collaboration with a veterinarian is crucial to create an individualized treatment plan tailored to the specific needs of the dog.
Prognose und Nachsorge
The prognosis for dogs with myelodystrophy is unfortunately unfavorable. The disease is progressive and typically leads to a progressive deterioration of neurological functions over time. Most affected dogs do not reach adulthood, as the progressive degeneration of the nervous system ultimately leads to severe impairments and complications.
In some cases, quality of life can be improved through symptomatic treatments and supportive care, but the long-term prognosis remains poor. Early diagnosis and the initiation of supportive measures can, however, help slow the progression of the disease and improve the animal’s well-being.
Prävention
Since myelodystrophy is a genetic disease, the best prevention strategy lies in responsible breeding practices. Breeders can use genetic tests to identify carriers of disease-causing mutations and avoid breeding two carriers together.
A better understanding of the genetic basis of the disease could lead to improved screening methods in the future. Through breeding selection and genetic testing, the incidence of the disease in affected breeds can potentially be reduced.
Furthermore, educating breeders and owners about the nature of the disease and the importance of genetic testing can help reduce the occurrence of the disease in the dog population. Collaboration with veterinary geneticists and participation in breeding programs aimed at reducing genetic diseases are important steps toward prevention.
Ausblick auf aktuelle Forschung
Myelodystrophy, also known as leukodystrophy or Afghan myelopathy, is a genetic neurological disease observed primarily in Afghan Hounds. This disease affects the central nervous system (CNS), particularly the spinal cord, and leads to progressive degeneration of the white matter. The exact cause of myelodystrophy is not yet fully understood, but it is believed that genetic mutations play a central role.
Current research is intensively searching for genetic markers responsible for susceptibility to this disease. Using modern genetic analysis techniques such as genome sequencing, scientists are attempting to identify specific genes or genetic variants associated with the disease. Veterinarians and geneticists are working together to develop genetic tests that enable early identification of carriers of the genetic defect. This could improve breeding strategies and help reduce the spread of the disease in the dog population.
Another research focus is on developing therapies that slow or even stop the progression of the disease. This also includes investigating potential drug candidates that could alleviate the symptoms of myelodystrophy. In addition to pharmacological research, there are also gene therapy approaches. These could offer a possibility in the future to directly correct the underlying genetic defects and thus prevent the development of the disease.
The role of environmental factors and their influence on the course of the disease is also being investigated. It is suspected that certain environmental conditions could worsen or influence the symptoms of myelodystrophy. With an understanding of these factors, researchers hope to develop preventive measures that can improve the well-being of affected dogs.
Frequently Asked Questions (FAQs)
1. What is myelodystrophy in dogs?
2. Which dog breeds are most commonly affected?
3. What symptoms do dogs with myelodystrophy show?
4. How is myelodystrophy diagnosed?
5. Is there a cure for myelodystrophy?
6. What treatment options are available for affected dogs?
7. Can genetic tests help with breeding?
8. What advances are there in research on myelodystrophy?
9. Is myelodystrophy comparable in humans and dogs?
10. How can I help my dog with myelodystrophy?
Literatur
- Averill, D. R., Jr., & Bronson, R. T. (1977). Inherited necrotizing myelopathy of Afghan hounds. Journal of Neuropathology and Experimental Neurology, 36(4), 734–747. https://doi.org/10.1097/00005072-197707000-00008
- Cummings, J. F., de Lahunta, A., & Summers, B. A. (1978). Hereditary myelopathy of Afghan hounds, a myelinolytic disease. Acta Neuropathologica, 42, 173–181.
- Oevermann, A., Bley, T., Konar, M., Lang, J., & Vandevelde, M. (2008). A novel leukoencephalomyelopathy of Leonberger dogs. Journal of Veterinary Internal Medicine, 22(2), 467–471. https://doi.org/10.1111/j.1939-1676.2008.0068.x
- Minor, K. M., Letko, A., Becker, D., Drögemüller, M., Mandigers, P. J. J., Bellekom, S. R., Leegwater, P. A. J., Stassen, Q. E. M., Putschbach, K., Fischer, A., Flegel, T., Matiasek, K., Ekenstedt, K. J., Furrow, E., Patterson, E. E., Platt, S. R., Kelly, P. A., Cassidy, J. P., Shelton, G. D., … Drögemüller, C. (2018). Canine NAPEPLD-associated models of human myelin disorders. Scientific Reports, 8, Article 5818. https://doi.org/10.1038/s41598-018-23938-7
- Störk, T., Nessler, J. N., Anderegg, L., Hünerfauth, E., Schmutz, I., Jagannathan, V., Kyöstilä, K., Lohi, H., Baumgärtner, W., Tipold, A., & Leeb, T. (2019). TSEN54 missense variant in Standard Schnauzers with leukodystrophy. PLoS Genetics, 15(10), Article e1008411. https://doi.org/10.1371/journal.pgen.1008411
- Baka, R. D., & Polizopoulou, Z. S. (2021). Hereditary myelopathies in dogs. Journal of the Hellenic Veterinary Medical Society, 72(1), 2583–2594. https://doi.org/10.12681/jhvms.26740